期刊文献+

特应性皮炎患者血清microRNA的差异性表达 被引量:3

Differential expression of serum microRNAs in atopic dermatitis
原文传递
导出
摘要 目的探讨深圳地区特应性皮炎(atopic dermatitis,AD)患者血清microRNA(miRNA)表达差异,为AD的早期诊断提供生物标志物。方法提取500例AD患者(AD组)和200例正常人(正常对照组)血清总RNA并进行miRNA测序,用实时荧光定量PCR验证差异表达的miRNA。结果与正常对照组相比,AD组患者血清中发现28个具有2倍以上差异的miRNA,其中21个miRNA在外周血血清中含量升高,7个miRNA在外周血血清中含量降低;对28个差异表达的miRNA采用实时荧光定量PCR进行验证,发现hsa-miR-186-5p、hsa-miR-409-3p、hsa-miR-423-5p、hsa-miR-6852-5p表达在AD患者外周血血清中升高。结论hsa-miR-186-5p、hsa-miR-409-3p、hsa-miR-423-5p、hsa-miR-6852-5p在AD的发病过程中可能起关键作用,对AD早期临床诊断有重要意义。 Objective To identify potential diagnostic biomarkers for atopic dermatitis by observing the changes of serum microRNA (miRNA) in atopic dermatitis (AD). Methods Serum miRNAs from 500 patients with AD and 200 healthy controls were sequenced, and the differentially expressed serum miRNAs were validated by fluorescence quantitative real-time PCR technique. Results In serum of AD patients, 28 differently expressed miRNAs (at least a 2-fold change compared with healthy control) were found. There were 21 up-regulated miRNAs and 7 down-regulated miRNAs in AD patients. Quantitative real-time PCR was adopted to confirm the results of sequencing, which showed hsa-miR-186-5p, hsa-miR-409 3p, hsa-miR-423-5p and hsa-miR-6852 5p were up-regulated in peripheral serum samples of AD patients. Conclusion Hsa-miR-186-5p, hsa-miR-409-3p, hsa-miR-423-5p and hsa-miR 6852 5p are the key to the development of atopic dermatitis and play important roles in the early diagnosis.
出处 《中华实用诊断与治疗杂志》 2016年第8期757-759,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 国家自然科学基金青年科学基金项目(81402600) 中国博士后科学基金面上资助项目(2014M562195)
关键词 特应性皮炎 MICRORNA 血清标志物 Atopic dermatitis microRNA biomarker
  • 相关文献

参考文献15

  • 1Bartel DP. MicroRNAs: target recognition and regulatory functions[J]. Ce11,2009,136(2) :215-233.
  • 2王胜春,宋俐,许庆强,王胜.150例特应性皮炎患儿皮肤屏障功能分析[J].中华实用诊断与治疗杂志,2014,28(8):786-787. 被引量:5
  • 3Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunetivitis, and eczema in childhood: ISAAC Phases One and Three Repeat Multicountry Cross-sectional Surveys[J]. Lancet, 2006,368 (9537) : 733-743.
  • 4Simpson EL, Keek LE, Chalmers JR, et al. How should an incident case of atopie dermatitis be defined? A systematic review of primary prevention studies[J]. J Allergy Clin Immunol, 2012, 130(1) : 137-144.
  • 5聂宇,张洋,韩变梅,王恺隽,丛祥凤,陈曦.常规TRIzol法提取血清microRNA的改良[J].中华实用诊断与治疗杂志,2011,25(5):427-428. 被引量:13
  • 6张杰,陈办成,陈娟,吴云,于波,邵勇,窦侠,彭曦,黄海艳,刘丽明.组胺H_4受体在特应性皮炎中的表达[J].中华实用诊断与治疗杂志,2015,29(7):676-677. 被引量:2
  • 7Lu TX, Munitz A, Rothenberg ME. MicroRNA-21 is up- regulated in allergic airway inflammation and regulates IL 12p35 expression[J]. J Immunol,2009,182(8):4994 5002.
  • 8Lu TX, Hartner J, Lira EJ, et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL 12/IFN gamma pathway, Thl polarization, and the severity of delayed-type hypersensitivity[J]. J Immuno1,2011,187(6) : 3362 3373.
  • 9Sawant DV, Wu H, Kaplan MH, et al. The Bcl6 target gene microRNA 21 promotes Th2 differentiation by a T cell intrinsic pathway[J]. Mol Immunol,2013,54(3/4) :435-442.
  • 10Ji X, Takahashi R, Hiura Y, et al. Plasma miR-208 as a biomarker of myocardial injury[J]. Clin (;hem, 2009,55 ( 11 ) : 1944 1949.

二级参考文献20

  • 1Proksch E, Brandner JM, Jensen JM. The skin: indispensable barrier[J]. Exp Dennatol, 2008,17(12):1063- 1072.
  • 2Cork MJ, Danby S. Skin barrier breakdown: a renaissance in emollient therapy[J]. Br J Nurs,2009,18(14) :872-877.
  • 3Warner RR, Myers MC, Taylor DA. Electron probe analysis of human skin: determination of the water concentration profile [J]. J Invest DermatoI,1988,90(2) 218-224.
  • 4Hachern JP, De Paepe K, Vanpee E, et al. Combination therapy improves the recovery of the skin barrier function: an experimental model using a contact allergy patch test combined with TEWL measurements[J]. J Dermatol, 2001,202 (4) : 314- 319.
  • 5Jayanta G, Emilie G, Mark BE, et al. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity[J]. J Allergy Clin lmnmnol, 2008,121 (3) .. 725-730.
  • 6Yu B, Shao Y, Zhang J, et al. Polymorphisms in human histamine receptor H4 gene are associated with atopic dermatitis [J]. Br J Dermatol,2010,162(5):1038-1043.
  • 7Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis [J]. Aeta Derm Venereol Suppl (Stockh), 1980,92 (Suppl) : 44- 47.
  • 8Nguyen T, Shapiro DA, George SR, et al. Discovery of a novel member of the histamine receptor family[J]. Mol Pharmacol, 2001,59(3) :427-433.
  • 9Daugherty BL. Histamine H4 antagonism: a therapy for chronic allergy? [J]. BrJ Pharmacol,2004,142(1):5-7.
  • 10Duneford PJ, O'donnell N, Riley JP, et al. The histamine H4 receptor mediates allergic airway inflammation by regulating allergic airway inflammation by regulating the activation of CD4+T cells[J]. J Immunol,2006,176(11) :7062-7070.

共引文献16

同被引文献23

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部